World Journal of Endocrine Surgery

Register      Login

VOLUME 5 , ISSUE 2 ( May-August, 2013 ) > List of Articles

CASE REPORT

Recurrent Medullary Carcinoma detected by Gallium-68 Positron Emission Tomography

Cigdem Soydal, Mine Araz, Ozlem N Kucuk, Elgin Ozkan, Taner Demirer

Citation Information : Soydal C, Araz M, Kucuk ON, Ozkan E, Demirer T. Recurrent Medullary Carcinoma detected by Gallium-68 Positron Emission Tomography. World J Endoc Surg 2013; 5 (2):59-60.

DOI: 10.5005/jp-journals-10002-1128

Published Online: 01-08-2013

Copyright Statement:  Copyright © 2013; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

How to cite this article

Soydal C, Ozkan E, Araz M, Kucuk ON, Demirer T. Recurrent Medullary Carcinoma detected by Gallium-68 Positron Emission Tomography. World J Endoc Surg 2013;5(2):59-60.


PDF Share
  1. Medullary thyroid cancer: management guidelines of the American Thyroid Association. American Thyroid Association Guidelines Task Force, Thyroid. 2009 Jun;19(6):565-612.
  2. Medullary thyroid cancer. Nuclear medicine in clinical diagnosis and treatment. 3rd ed. London: Churchill Livingstone; 2004;P165-174.
  3. 18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels. Eur J Nucl Med 2001 Jan;28(1):64-71.
  4. The value of fluorine-18 fluorodeoxyglucose PET in patients with medullary thyroid cancer. Eur J Nucl Med 2000 May;27(5):490-496.
  5. Impact of 18F-fluoro-2- deoxy-D-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer. Ann Surg Oncol 2004 Aug;11(8):786-794.
  6. The role of PETCT scan with somatostatin analogue labelled with gallium-68 (68Ga-DOTATATE PETCT) in diagnosing patients with disseminated medullary thyroid carcinoma (MTC). Endokrynol Pol 2010 Sep-Oct;61(5):507-511.
  7. Preliminary experience with (68)Ga-DOTA-lanreotide positron emission tomography. QJ Nucl Med Mol Imaging 2010 Feb;54(1):52-60.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.